Theseus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Cash & Equivalents	-	278.6	266.5	441.6	106.53	102.68	Upgrade
Short-Term Investments	-	13.2	0.9	0.9	480.74	400.36	Upgrade
Trading Asset Securities	-	4,081	2,474	2,194	2,087	2,803	Upgrade
Cash & Short-Term Investments	4,373	4,373	2,742	2,637	2,674	3,306	Upgrade
Cash Growth	59.51%	59.51%	3.97%	-1.40%	-19.10%	-4.24%	Upgrade
Accounts Receivable	-	5,419	5,797	4,989	4,464	4,071	Upgrade
Other Receivables	-	347.7	219.1	236.7	646.09	619.61	Upgrade
Receivables	-	5,766	6,016	5,226	5,110	4,691	Upgrade
Inventory	-	7,962	8,749	8,309	9,793	8,032	Upgrade
Prepaid Expenses	-	54.8	37	47	145.66	144.61	Upgrade
Other Current Assets	-	499.6	260.1	225.3	216.29	380.78	Upgrade
Total Current Assets	-	18,655	17,803	16,444	17,939	16,554	Upgrade
Property, Plant & Equipment	-	7,042	8,070	7,296	6,196	5,299	Upgrade
Long-Term Investments	-	90.4	72.5	83.2	55.44	38.81	Upgrade
Goodwill	-	1,958	1,958	1,958	1,958	1,958	Upgrade
Other Intangible Assets	-	546.4	650.3	690.8	852.89	696.06	Upgrade
Other Long-Term Assets	-	1,453	1,480	1,506	1,579	1,340	Upgrade
Total Assets	-	29,745	30,035	27,977	28,580	25,886	Upgrade
Accounts Payable	-	5,412	5,998	5,883	7,525	5,961	Upgrade
Accrued Expenses	-	200.2	181.1	150	162.91	182.93	Upgrade
Short-Term Debt	-	-	-	1,000	501.66	300.48	Upgrade
Current Portion of Long-Term Debt	-	4.7	4.7	11.3	39.91	37.8	Upgrade
Current Portion of Leases	-	121.5	203.1	119.1	131.42	124.46	Upgrade
Current Income Taxes Payable	-	34.3	18.2	32.6	28.41	41.13	Upgrade
Other Current Liabilities	-	3,915	3,778	2,693	2,377	2,497	Upgrade
Total Current Liabilities	-	9,687	10,183	9,888	10,767	9,145	Upgrade
Long-Term Debt	-	6.1	10.8	26.6	37.93	77.83	Upgrade
Long-Term Leases	-	498.7	1,118	210	216.51	215.53	Upgrade
Long-Term Unearned Revenue	-	10.7	12.4	14	0.68	0.83	Upgrade
Long-Term Deferred Tax Liabilities	-	59.5	5.7	122.9	213.35	263.81	Upgrade
Other Long-Term Liabilities	-	190.5	172.2	177.5	145.88	36.13	Upgrade
Total Liabilities	-	10,702	11,740	10,677	11,614	9,971	Upgrade
Common Stock	-	194.5	194.5	194.5	194.47	194.47	Upgrade
Additional Paid-In Capital	-	1,730	1,730	1,730	879.39	879.39	Upgrade
Retained Earnings	-	16,176	15,428	14,439	14,953	13,895	Upgrade
Comprehensive Income & Other	-	942.9	942.9	937.3	939.74	938.8	Upgrade
Total Common Equity	19,043	19,043	18,295	17,301	16,967	15,908	Upgrade
Minority Interest	-	-	-	-	-	6.86	Upgrade
Shareholders' Equity	19,043	19,043	18,295	17,301	16,967	15,915	Upgrade
Total Liabilities & Equity	-	29,745	30,035	27,977	28,580	25,886	Upgrade
Total Debt	631	631	1,337	1,367	927.42	756.11	Upgrade
Net Cash (Debt)	3,742	3,742	1,405	1,270	1,747	2,550	Upgrade
Net Cash Growth	166.43%	166.43%	10.60%	-27.31%	-31.49%	1.34%	Upgrade
Net Cash Per Share	19.26	19.24	7.22	6.53	8.98	13.11	Upgrade
Filing Date Shares Outstanding	194.27	194.47	194.47	194.47	194.47	194.47	Upgrade
Total Common Shares Outstanding	194.27	194.47	194.47	194.47	194.47	194.47	Upgrade
Working Capital	-	8,968	7,620	6,556	7,173	7,409	Upgrade
Book Value Per Share	97.92	97.92	94.08	88.96	87.25	81.80	Upgrade
Tangible Book Value	16,538	16,538	15,686	14,652	14,155	13,254	Upgrade
Tangible Book Value Per Share	85.04	85.04	80.66	75.34	72.79	68.15	Upgrade
Land	-	421.7	407.1	400.5	403.7	402.73	Upgrade
Buildings	-	3,094	3,030	2,153	2,042	1,539	Upgrade
Machinery	-	7,076	6,698	5,569	5,261	4,125	Upgrade
Construction In Progress	-	248.8	190.8	1,794	557.3	1,057	Upgrade
Leasehold Improvements	-	114.3	114.3	112.4	103.85	42.26	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.